ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells.

about

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression.

P2860

Q28068581-339B22FA-7899-4E61-8379-8F9E62B0F521 Q37699390-5A5FCF96-7558-4C29-8072-F2D38AEA3C83

P2860

ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells.

Item

http://www.wikidata.org/entity/Q38809831

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

ASK1/JNK-mediated TAp63 activa ...... eated EBV-transformed B cells.

@en

type

Item

label

ASK1/JNK-mediated TAp63 activa ...... eated EBV-transformed B cells.

@en

prefLabel

ASK1/JNK-mediated TAp63 activa ...... eated EBV-transformed B cells.

@en

P1476

ASK1/JNK-mediated TAp63 activa ...... eated EBV-transformed B cells.

@en

P2093

Dae Young Hur

http://www.w3.org/2001/XMLSchema#string

Daejin Kim

http://www.w3.org/2001/XMLSchema#string

Ga Bin Park

http://www.w3.org/2001/XMLSchema#string

Hyun-Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Jae Wook Yang

http://www.w3.org/2001/XMLSchema#string

Yeong Seok Kim

http://www.w3.org/2001/XMLSchema#string

P2860

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex

p63 is an essential proapoptotic protein during neural development

Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

p53 associates with and targets Delta Np63 into a protein degradation pathway

Assembly, transport, and function of MHC class II molecules.

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.

Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin.

CD74: a new candidate target for the immunotherapy of B-cell neoplasms.

P2888

s11010-015-2631-8

P304

247-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-015-2631-8

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

412

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020499623

http://www.w3.org/2001/XMLSchema#string

P698

26694167

http://www.w3.org/2001/XMLSchema#string

ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells.

about

P2860

P2860

ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698